Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gennaro Musi

Showing results (131-140 of 266) with videos related to

Pageof 27
Sort By:
Neoplasma|January 11, 2022
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysisGiulia Corrao, Giulia Marvaso, Mattia Zaffaroni, et al.
Annals of Surgical Oncology|March 6, 2026
ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
European Urology Open Science|August 2, 2021
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective StudiesGiulia Marvaso, Stefania Volpe, Matteo Pepa, et al.
Minerva Urology and Nephrology|November 4, 2024
Validation of lymphovascular invasion as a predictor of lymph-node invasion in squamous cell carcinoma of the penisLetizia M Jannello, Mario De Angelis, Carolin Siech, et al.
Tumori|May 27, 2026
Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancerCostantino Putzu, Federico Mastroleo, Mattia Zaffaroni, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> AchievementAldo Brassetti, Umberto Anceschi, Gabriele Cozzi, et al.
The Prostate|July 8, 2026
Years of Life Lost in Incidental Prostate CancerFabian Falkenbach, Mattia Longoni, Andrea Marmiroli, et al.
Minerva Endocrinology|September 30, 2024
Inpatient palliative care in metastatic adrenocortical carcinoma: a retrospective analysis using the National Inpatient Sample databaseLetizia M Jannello, Carolin Siech, Andrea Baudo, et al.
Cancers|May 14, 2022
Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy AloneFrancesco A Mistretta, Stefano Luzzago, Andrea Conti, et al.
La Radiologia Medica|July 16, 2024
Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomySarah Alessi, Roberta Maggioni, Stefano Luzzago, et al.
Pageof 27

Showing results (131-140 of 266) with videos related to

Sort By:
Pageof 27
Neoplasma|January 11, 2022
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysisGiulia Corrao, Giulia Marvaso, Mattia Zaffaroni, et al.
Annals of Surgical Oncology|March 6, 2026
ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical NephrectomyMaximilian Filzmayer, Michele Nicolazzini, Calogero Catanzaro, et al.
European Urology Open Science|August 2, 2021
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective StudiesGiulia Marvaso, Stefania Volpe, Matteo Pepa, et al.
Minerva Urology and Nephrology|November 4, 2024
Validation of lymphovascular invasion as a predictor of lymph-node invasion in squamous cell carcinoma of the penisLetizia M Jannello, Mario De Angelis, Carolin Siech, et al.
Tumori|May 27, 2026
Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancerCostantino Putzu, Federico Mastroleo, Mattia Zaffaroni, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The <i>Tetrafecta</i> AchievementAldo Brassetti, Umberto Anceschi, Gabriele Cozzi, et al.
The Prostate|July 8, 2026
Years of Life Lost in Incidental Prostate CancerFabian Falkenbach, Mattia Longoni, Andrea Marmiroli, et al.
Minerva Endocrinology|September 30, 2024
Inpatient palliative care in metastatic adrenocortical carcinoma: a retrospective analysis using the National Inpatient Sample databaseLetizia M Jannello, Carolin Siech, Andrea Baudo, et al.
Cancers|May 14, 2022
Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy AloneFrancesco A Mistretta, Stefano Luzzago, Andrea Conti, et al.
La Radiologia Medica|July 16, 2024
Association between mpMRI detected tumor apparent diffusion coefficient and 5-year biochemical recurrence risk after radical prostatectomySarah Alessi, Roberta Maggioni, Stefano Luzzago, et al.
Pageof 27